Semmax Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.95M Buy
118,076
+3,916
+3% +$91.3K 0.76% 51
2025
Q1
$2.54M Buy
114,160
+10,778
+10% +$282K 0.69% 56
2024
Q4
$2.7M Buy
103,382
+2,115
+2% +$57.4K 0.72% 55
2024
Q3
$2.69M Buy
101,267
+3,185
+3% +$92.9K 0.74% 54
2024
Q2
$2.87M Sell
98,082
-21,769
-18% -$599K 0.86% 51
2024
Q1
$3.46M Buy
119,851
+11,021
+10% +$306K 1.14% 36
2023
Q4
$2.98M Buy
108,830
+22,539
+26% +$681K 1.09% 37
2023
Q3
$2.54M Buy
+86,291
New +$3.05M 1.02% 41
2022
Q4
$2.43M Buy
52,720
+665
+1% +$31.9K 0.97% 38
2022
Q3
$2.47M Buy
52,055
+4,000
+8% +$194K 1.05% 34
2022
Q2
$2.42M Buy
48,055
+2,220
+5% +$113K 0.99% 42
2022
Q1
$2.37M Buy
45,835
+2,776
+6% +$144K 0.93% 42
2021
Q4
$2.54M Sell
43,059
-83,389
-66% -$4.13M 0.94% 45
2021
Q3
$5.44M Sell
126,448
-9,899
-7% -$439K 1.88% 12
2021
Q2
$5.34M Buy
136,347
+5,969
+5% +$232K 1.71% 13
2021
Q1
$4.72M Buy
130,378
+8,174
+7% +$290K 1.68% 12
2020
Q4
$4.5M Sell
122,204
-3,510
-3% -$129K 1.86% 13
2020
Q3
$4.38M Buy
125,714
+5,092
+4% +$179K 2.08% 13
2020
Q2
$3.74M Buy
120,622
+11,819
+11% +$402K 1.96% 13
2020
Q1
$3.37M Buy
108,803
+8,373
+8% +$285K 2.14% 10
2019
Q4
$3.73M Buy
100,430
+7,547
+8% +$269K 2.06% 11
2019
Q3
$3.17M Buy
92,883
+29,589
+47% +$1.08M 1.9% 12
2019
Q2
$2.6M Buy
63,294
+33,372
+112% +$1.33M 1.68% 16
2019
Q1
$1.21M Buy
29,922
+15,807
+112% +$633K 0.83% 28
2018
Q4
$585K Buy
+14,115
New +$586K 0.46% 57

Other funds holding PFE

Semmax Financial Advisors's PFE Position: Q2 2025 in Review

Semmax Financial Advisors increased its Pfizer (PFE) stake by 3.4% in Q2 2025, buying an estimated $91.3K and bringing the position to 118,076 shares worth $2.95M. The position accounts for 0.76% of the portfolio, ranked #51.

Semmax Financial Advisors first reported a position in PFE in Q4 2018 and has held it in 25 quarters since. The position peaked at $5.44M in Q3 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Semmax Financial Advisors held 118,076 shares of Pfizer worth $2.95M as of Q2 2025.
  • Semmax Financial Advisors bought 3,916 Pfizer shares in Q2 2025, an estimated $91.3K.
  • Pfizer made up 0.76% of Semmax Financial Advisors's portfolio in Q2 2025, its #51 holding.
  • Semmax Financial Advisors first reported a position in Pfizer in Q4 2018 and has held it in 25 quarters since.
  • Semmax Financial Advisors's Pfizer position peaked at $5.44M in Q3 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.